<table id="table4" width="100%" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption>TABLE 4:  Effect of Coadministered Drugs on Total Ezetimibe</caption>
<col align="left" span="1" valign="top" width="50%"></col>
<col align="center" span="1" valign="top" width="25%"></col>
<col align="center" span="1" valign="top" width="25%"></col>
<tbody>
<tr>
<th colspan="1">Coadministered Drug and Dosing Regimen</th>
<th colspan="2">Total Ezetimibe <linkhtml href="#footnote-1">*</linkhtml>
</th>
</tr>
<tr>
<th colspan="1"></th>
<th colspan="1">Change in AUC</th>
<th colspan="1">Change in C<sub>max</sub>
</th>
</tr>
<tr>
<td>Cyclosporine-stable dose required (75–150 mg BID)<linkhtml href="#footnote-2">†</linkhtml>
<sup>,</sup>
<linkhtml href="#footnote-3">‡</linkhtml>
</td>
<td>↑240%</td>
<td>↑290%</td>
</tr>
<tr>
<td>Fenofibrate, 200 mg QD, 14 days<footnoteref idref="t4ft2"></footnoteref>
</td>
<td>↑48%</td>
<td>↑64%</td>
</tr>
<tr>
<td>Gemfibrozil, 600 mg BID, 7 days<footnoteref idref="t4ft2"></footnoteref>
</td>
<td>↑64%</td>
<td>↑91%</td>
</tr>
<tr>
<td>Cholestyramine, 4 g BID, 14 days<footnoteref idref="t4ft2"></footnoteref>
</td>
<td>↓55%</td>
<td>↓4%</td>
</tr>
<tr>
<td>Aluminum &amp; magnesium hydroxide combination antacid, single dose<linkhtml href="#footnote-4">§</linkhtml>
</td>
<td>↓4%</td>
<td>↓30%</td>
</tr>
<tr>
<td>Cimetidine, 400 mg BID, 7 days</td>
<td>↑6%</td>
<td>↑22%</td>
</tr>
<tr>
<td>Glipizide, 10 mg, single dose</td>
<td>↑4%</td>
<td>↓8% </td>
</tr>
<tr>
<td>
<content stylecode="bold">Statins</content>
</td>
<td></td>
<td></td>
</tr>
<tr>
<td>  Lovastatin 20 mg QD, 7 days</td>
<td>↑9%</td>
<td>↑3%</td>
</tr>
<tr>
<td>  Pravastatin 20 mg QD, 14 days</td>
<td>↑7%</td>
<td>↑23%</td>
</tr>
<tr>
<td>  Atorvastatin 10 mg QD, 14 days</td>
<td>↓2%</td>
<td>↑12%</td>
</tr>
<tr>
<td>  Rosuvastatin 10 mg QD, 14 days</td>
<td>↑13%</td>
<td>↑18%</td>
</tr>
<tr>
<td>  Fluvastatin 20 mg QD, 14 days</td>
<td>↓19%</td>
<td>↑7%</td>
</tr>
</tbody>
</table>